Excessive Intraoperative Blood Loss Independently Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2015 Oct 17

PMID 26472203

Citations 7

Authors

Bing Liu

Fei Teng

Hong Fu

Wen-Yuan Guo

Xiao-Min Shi

Zhi-Jia Ni

Xiao-Gang Gao

Jun Ma

Zhi-Ren Fu

Guo-Shan Ding

Affiliations

Soon will be listed here.

Abstract

Background: Several studies have investigated the effect of intraoperative blood loss (IBL) on recurrence of tumors. However, the independent effect of IBL on oncological outcome after liver transplantation (LT) for hepatocellular carcinoma (HCC) is unclear.

Methods: A total of 479 patients who underwent LT for HCC from January 2001 to December 2012 at our institution were enrolled in this retrospective study. Kaplan-Meier and Cox regression methods were used to assess the recurrence rate, as well as its risk factors. Stratified analysis was performed to further examine the effect of IBL on HCC recurrence according to different characteristics of tumors. We also investigated the independent risk factors for excessive IBL using logistic regression analysis.

Results: The median follow-up was 28 months (range, 1-131 months). Kaplan-Meier analysis with the log-rank test according to IBL at per liter intervals showed that IBL > 4 L was significantly associated with a higher recurrence rate (P < 0.001). Multivariate analysis identified that IBL > 4 L (P < 0.001; hazard ratio [HR] = 2.32, 95 % confidence interval [CI] = 1.60-3.36) was an independent risk factor for post-LT HCC recurrence, as well as age < 60 years, exceeding Milan criteria, α-fetoprotein levels > 400 ng/mL, and micro- and macrovascular invasion. IBL > 4 L (P < 0.001; HR = 2.45, 95 % CI = 1.64-3.66) was also independently associated with early (within 1 year) recurrence after LT. Furthermore, a significant correlation between IBL > 4 L and vascular invasion (P = 0.019) was found. IBL > 4 L was independently associated with HCC recurrence for patients with vascular invasion, but not for patients without vascular invasion. Finally, we found that the presence of ascites, model for end-stage liver disease score, and operation time were independent risk factors for IBL > 4 L.

Conclusions: Excessive IBL is an independent predictor of HCC recurrence after LT, especially in patients with vascular invasion.

Citing Articles

Association between Unplanned Conversion and Patient Survival after Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Propensity Score Matched Analysis.

Lee B, Cho J, Han H, Yoon Y, Lee H, Kang M J Clin Med. 2024; 13(4).

PMID: 38398431 PMC: 10889730. DOI: 10.3390/jcm13041116.

A practical recurrence risk model based on Lasso-Cox regression for gastric cancer.

Huang B, Ding F, Li Y J Cancer Res Clin Oncol. 2023; 149(17):15845-15854.

PMID: 37672074 DOI: 10.1007/s00432-023-05346-1.

Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections.

Gul-Klein S, Kastner A, Haber P, Krenzien F, Wabitsch S, Krannich A J Hepatocell Carcinoma. 2021; 8:133-143.

PMID: 33777855 PMC: 7987264. DOI: 10.2147/JHC.S292010.

Is left-sided involvement of hepatocellular carcinoma an important preoperative predictive factor of poor outcome?.

Sakuraoka Y, Kubota K, Tanaka G, Shimizu T, Tago K, Park K World J Surg Oncol. 2020; 18(1):317.

PMID: 33272298 PMC: 7716469. DOI: 10.1186/s12957-020-02100-6.

Importance of Intraoperative Transfusions of Packed Red Blood Cells and Fresh Frozen Plasma in Liver Transplantation for Hepatocellular Cancer.

Masior L, Grat M, Grat K, Krasnodebski M, Wronka K, Stypulkowski J Ann Transplant. 2020; 25:e923665.

PMID: 33079923 PMC: 7552880. DOI: 10.12659/AOT.923665.

References

Bruix J, Gores G, Mazzaferro V . Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014; 63(5):844-55. PMC: 4337888. DOI: 10.1136/gutjnl-2013-306627. View

Feltracco P, Brezzi M, Barbieri S, Galligioni H, Milevoj M, Carollo C . Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol. 2013; 5(1):1-15. PMC: 3562721. DOI: 10.4254/wjh.v5.i1.1. View

Liang Y, Guo H, Deng J, Wang B, Ding X, Wang X . Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol. 2013; 19(33):5542-50. PMC: 3761109. DOI: 10.3748/wjg.v19.i33.5542. View

Sasaki K, Matsuda M, Ohkura Y, Kawamura Y, Inoue M, Hashimoto M . Factors associated with early cancer-related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion. J Hepatobiliary Pancreat Sci. 2013; 21(2):142-7. DOI: 10.1002/jhbp.13. View

Xia V, Fond A, DU B . Ascites, but not hyponatremia, is associated with high intraoperative transfusion and vasopressor requirements during liver transplantation. Transplant Proc. 2006; 38(5):1398-9. DOI: 10.1016/j.transproceed.2006.02.107. View

Jubert A, Lee E, Hersh E, McBride C . Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res. 1973; 15(6):399-403. DOI: 10.1016/0022-4804(73)90110-8. View

Teng F, Wang G, Tao Y, Guo W, Wang Z, Ding G . Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol. 2014; 20(31):10900-7. PMC: 4138469. DOI: 10.3748/wjg.v20.i31.10900. View

Yao F, Ferrell L, Bass N, Watson J, Bacchetti P, Venook A . Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001; 33(6):1394-403. DOI: 10.1053/jhep.2001.24563. View

Yuasa T, Niwa N, Kimura S, Tsuji H, Yurugi K, Egawa H . Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center. Transfusion. 2005; 45(6):879-84. DOI: 10.1111/j.1537-2995.2005.04330.x. View

10.

Morner M, Gunnarsson U, Jestin P, Svanfeldt M . The importance of blood loss during colon cancer surgery for long-term survival: an epidemiological study based on a population based register. Ann Surg. 2012; 255(6):1126-8. DOI: 10.1097/SLA.0b013e3182512df0. View

11.

Kaido T, Takada Y, Egawa H, Uemoto S . The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma. Hepatogastroenterology. 2009; 56(91-92):808-12. View

12.

Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T . Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012; 143(4):986-94.e3. DOI: 10.1053/j.gastro.2012.05.052. View

13.

Taketomi A, Toshima T, Kitagawa D, Motomura T, Takeishi K, Mano Y . Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2010; 17(10):2740-6. DOI: 10.1245/s10434-010-1076-2. View

14.

Nagai S, Fujii T, Kodera Y, Kanda M, Sahin T, Kanzaki A . Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas. 2010; 40(1):3-9. DOI: 10.1097/MPA.0b013e3181f7147a. View

15.

Cywinski J, Alster J, Miller C, Vogt D, Parker B . Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival. Anesth Analg. 2014; 118(2):428-437. DOI: 10.1213/ANE.0b013e3182a76f19. View

16.

Agarwal S, Joyner Jr K, Swaim M . Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol. 2000; 95(11):3218-24. DOI: 10.1111/j.1572-0241.2000.03299.x. View

17.

Oefelein M, Colangelo L, Rademaker A, McVary K . Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol. 1995; 154(2 Pt 1):442-7. DOI: 10.1097/00005392-199508000-00029. View

18.

Huang J, Li B, Chen G, Li J, Zhang Y, Li G . Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg. 2009; 13(9):1627-35. DOI: 10.1007/s11605-009-0933-4. View

19.

Rana A, Petrowsky H, Hong J, Agopian V, Kaldas F, Farmer D . Blood transfusion requirement during liver transplantation is an important risk factor for mortality. J Am Coll Surg. 2013; 216(5):902-7. DOI: 10.1016/j.jamcollsurg.2012.12.047. View

20.

Katz S, Shia J, Liau K, Gonen M, Ruo L, Jarnagin W . Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009; 249(4):617-23. DOI: 10.1097/SLA.0b013e31819ed22f. View